Dr. Robert P. Witherspoon

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Clinical Research
MemberAppointed: 2002
University of Washington
School of Medicine
Medicine
Oncology
ProfessorAppointed: 2005
Fred Hutchinson Cancer Research Center
Seattle Cancer Care Alliance
Transplant Clinic
Medical DirectorAppointed: 2001
Professional Headshot of Robert P. Witherspoon

Mailing Address

Fred Hutchinson Cancer Research Center
1100 Fairview Avenue N., D5-280
P.O. Box 19024
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-4551
Fax: (206) 667-5899
rwithers@fhcrc.org

Qualifications

M.S., Baylor University, 1970.
M.D., Baylor College of Medicine, 1970.

Expertise and Research Interests

Medical Oncology with a special interest in bone marrow transplantation for treatment of hematopoietic and non-hematopoietic disease. Immunologic recovery, graft-versus-host disease clinical trials, supportive care, secondary malignancies, and long term outcomes following hematopoietic stem cell transplantation. Treatment strategies for treatment-related myelodysplasia and leukemia.

Keywords

COS Keywords:

Hematology, Leukemia, Oncology, Stem Cells.

Additional Terms:

Hematopoietic Stem Cell Transplantation.

Languages

(Reading, Writing, Speaking)

German: (Functional, Functional, Functional)
Japanese: (Basic, Basic, Basic)

Memberships

American Cancer Society
American College of Physicians
American Society for Blood and Bone Marrow Transplantation
American Society of Clinical Oncology
American Society of Hematology
American Society of Internal Medicine
International Society for Experimental Hematology
Phi Beta Kappa
Sigma Xi, The Scientific Research Society

Honors and Awards

Sigma Xi, 1970, Baylor University Medical Graduate Chapter
Phi Beta Kappa, 1965, Wabash College
Magna cum laude, 1965, Wabash College

Previous Positions

1996-2000, Medical Director, Fred Hutchinson Cancer Research Center, Ambulatory Clinic
1993-1996, Medical Director, Fred Hutchinson Cancer Research Center
1990-1993, Pre-admission Medical Director, Fred Hutchinson Cancer Research Center, Department of Medical Oncology
1984, Associate Member, Fred Hutchinson Cancer Research Center, Oncology, Division of Clinical Research
1984, Associate Professor, University of Washington, School of Medicine, Department of Medicine, Division of Oncology
1979-1984, Assistant Member, Fred Hutchinson Cancer Research Center, Medical Oncology, Division of Clinical Research
1978-1979, Associate Member, Fred Hutchinson Cancer Research Center, Department of Medical Oncology
1978-1984, Assistant Professor, University of Washington, School of Medicine, Department of Medicine, Division of Medical Oncology
1976-1978, Acting Instructor, University of Washington, School of Medicine, Department of Medicine, Division of Oncology
1974-1976, Major, U.S.A.-M.C., Assistant Chief, Brooke Army Medical Center, Fort Sam Houston, Texas, Oncology Service
1973-1974, Senior Fellow, University of Washington, School of Medicine, Department of Medicine
1971-1973, Resident, University of Washington, School of Medicine, Department of Medicine
1970-1971, Intern, University of Washington, School of Medicine, Department of Medicine

Funding Received

  • National Institutes of Health/National Cancer Institute: Adult Leukemia Reserch Center (PENDING), Dec 1, 2001 to Nov 30, 2006.
  • National Institutes of Health/National Heart, Lung, Blood Institute: Stem Cell Transplanttion, Aug 1, 2001 to Jul 31, 2006.

Publications

  • McDonald GB, McCune JS, Batchelder A, Cole S, Phillips B, Ren AG, Vicini P, Witherspoon R, Kalhorn TF, Slattery JT (Sep 2005) Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant., Clinical Pharmacology and Therapeutics, 78 (3), 298-308 Abstract
  • Hallstrand TS, Sprenger JD, Agosti JM, Longton GM, Witherspoon RP, Henderson WR Jr (Nov 2004) Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors., Blood, 104 (10), 3086-90 Abstract
  • Storek J, Dawson MA, Lim LC, Burman BE, Stevens-Ayers T, Viganego F, Herremans MM, Flowers ME, Witherspoon RP, Maloney DG, Boeckh M (Feb 2004) Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation., Bone Marrow Transplantation, 33 (3), 337-46 Abstract
  • Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, Johnston L, Ponisch W, Epner E, Witherspoon R, Blume K, Storb R (Nov 2003) Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 9 (11), 689-97 Abstract
  • Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, Kiem HP, Martin PJ, Petersdorf E, Radich JP, Sanders JE, Shulman HM, Warren EH, Witherspoon RP, Bryant EM, Chauncey TR, Getzendaner L, Storb R, Appelbaum FR, Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome, Blood, 100(4), 1201-7, Aug 2002 Abstract
  • Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Storb R, Appelbaum FR, Martin PJ, Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone, Blood, 100(1), 48-51, July 2002 Abstract
  • Platzbecker U, Gooley T, Anasetti C, Appelbaum FR, Clurman B, Doney K, Chauncey T, Flowers ME, Myerson D, Radich JP, Storb R, Witherspoon RP, Deeg HJ (Jul 2002) Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation., Leukemia & Lymphoma, 43 (7), 1409-14 Abstract
  • Jurado M, Deeg HJ, Storer B, Anasetti C, Anderson JE, Bryant E, Chauncey T, Doney K, Flowers MED, Hansen J, Martin PJ, Nash RA, Petersdorf E, Radich J, Sale G, Sandmaier BM, Storb R, Wade J, Witherspoon R, Appelbaum FR, Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considera, Biology of Blood and Marrow Transplantation, 8(3), 161-169, 2002
  • Kansu E, Gooley T, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ, Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial, Blood, 98(13), 3868-70, December 2001 Abstract
  • Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, Storb R, Appelbaum FR, Boeckh M, Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation, Blood, 97(11), 3380-9, June 2001 Abstract
  • Witherspoon RP, Deeg HJ, Storer B., Anasetti C., Storb R., Appelbaum FR, Hematopoietic stem cell transplantation for treatment-related leukemia or myelodysplasia, Journal of Clinical Oncology, 19, 2134-2141, 2001
  • Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers MED, Martin P, Storb R., Appelbaum FR, Boeckh M, Immune reconstitution after allogeneic marrow versus blood stem cell transplantation, Blood, 97, 3380-3389, 2001
  • Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, Flowers M, Sullivan KM, Witherspoon RP, Rowley SD, Hansen JA, Storb R, Appelbaum FR, Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease, Blood, 90(12), 4705-9, December 1997 Abstract
  • Storb R, Leisenring W, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan KM, Witherspoon R, Pettinger M, Bensinger W, Buckner CD, Clift R, Flowers ME, Hansen JA, Pepe M, Chauncey T, Sanders J, Thomas ED, Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 3(4), 194-201, October 1997 Abstract
  • Deeg HJ, Lin D, Leisenring W, Boeckh M, Anasetti C, Appelbaum FR, Chauncey TR, Doney K, Flowers M, Martin P, Nash R, Schoch G, Sullivan KM, Witherspoon RP, Storb R, Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial., Blood, 89(10), 3880-7, 15 1997 Abstract
  • Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, Chauncey T, Clift RA, Deeg HJ, Doney KC, Flowers ME, Hansen JA, Martin PJ, Sanders JE, Sullivan KM, Witherspoon RP, Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin, Blood, 89(10), 3890-1, May 1997 Abstract
  • Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr, Solid cancers after bone marrow transplantation, The New England Journal of Medicine, 336(13), 897-904, March 1997 Abstract
  • Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R, Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts., American Journal of Hematology, 54(2), 131-8, 1997 Abstract
  • Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R, Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients., Blood, 87(1), 386-92, 1 1996 Abstract
  • Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Chauncey TR, Clift RA, Doney K, Flowers M, Hansen JA, Martin PJ, Matthews DC, Sanders JE, Shulman H, Sullivan KM, Witherspoon RP, Storb R, Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors., Blood, 87(1), 51-8, 1 1996 Abstract
  • Storek J, Witherspoon RP, Storb R, T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life., Bone Marrow Transplantation, 16(3), 413-25, 1995 Abstract
  • Witherspoon RP, Deeg HJ, Storb R, Secondary malignancies after marrow transplantation for leukemia or aplastic anemia., Transplantation, 57(10), 1413-8, 27 1994 Abstract
  • Sanders JE, Storb R, Anasetti C, Deeg HJ, Doney K, Sullivan KM, Witherspoon RP, Hansen J, Marrow transplant experience for children with severe aplastic anemia, The American Journal of Pediatric Hematology/oncology, 16(1), 43-9, February 1994 Abstract
  • Petersen FB, Buckner CD, Appelbaum FR, Sanders JE, Bensinger WI, Storb R, Deeg HJ, Witherspoon RP, Sullivan KM, Clift RA, et al., Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I stud, Bone Marrow Transplantation, 10(1), 83-8, July 1992 Abstract
  • Flowers ME, Doney KC, Storb R, Deeg HJ, Sanders JE, Sullivan KM, Bryant E, Witherspoon RP, Appelbaum FR, Buckner CD, et al., Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience, Bone Marrow Transplantation, 9(3), 167-73, March 1992 Abstract
  • Petersen FB, Deeg HJ, Buckner CD, Appelbaum FR, Storb R, Clift RA, Sanders JE, Bensinger WI, Witherspoon RP, Sullivan KM, et al., Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial, International Journal of Radiation Oncology, Biology, Physics, 23(5), 1027-32, 1992 Abstract
  • Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger W, Bowden R, Buckner CD, et al., Late complications of allogeneic and autologous marrow transplantation, Bone Marrow Transplantation, 10 Suppl 1, 127-34, 1992 Abstract
  • Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Peterson FB, Witherspoon RP, et al., Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation, The New England Journal of Medicine, 323(11), 705-12, September 1990 Abstract
  • Storb R, Pepe M, Anasetti C, Appelbaum FR, Beatty P, Doney K, Martin P, Stewart P, Sullivan KM, Witherspoon R, et al., What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?, Blood, 76(5), 1037-45, September 1990 Abstract
  • Loughran TP Jr, Sullivan K, Morton T, Beckham C, Schubert M, Witherspoon R, Sale G, Sanders J, Fisher L, Shulman H, et al., Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation, Blood, 76(1), 228-34, July 1990 Abstract
  • Schubert MA, Sullivan KM, Schubert MM, Nims J, Hansen M, Sanders JE, O'Quigley J, Witherspoon RP, Buckner CD, Storb R, et al., Gynecological abnormalities following allogeneic bone marrow transplantation, Bone Marrow Transplantation, 5(6), 425-30, June 1990 Abstract
  • Flowers ME, Pepe MS, Longton G, Doney KC, Monroe D, Witherspoon RP, Sullivan KM, Storb R, Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation, British Journal of Haematology, 74(4), 492-6, April 1990 Abstract
  • Petersen FB, Appelbaum FR, Hill R, Fisher LD, Bigelow CL, Sanders JE, Sullivan KM, Bensinger WI, Witherspoon RP, Storb R, et al., Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 8(4), 638-47, April 1990 Abstract
  • Sanders J, Sullivan K, Witherspoon R, Doney K, Anasetti C, Beatty P, Petersen FB, Long term effects and quality of life in children and adults after marrow transplantation, Bone Marrow Transplantation, 4 Suppl 4, 27-9, December 1989 Abstract
  • Petersen FB, Buckner CD, Appelbaum FR, Clift RA, Sanders JE, Bensinger WI, Storb R, Witherspoon RP, Sullivan KM, Bearman SI, et al., Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study, Bone Marrow Transplantation, 4(6), 617-23, November 1989 Abstract
  • Sullivan KM, Witherspoon RP, Storb R, Buckner CD, Sanders J, Thomas ED, Long-term results of allogeneic bone marrow transplantation, Transplantation Proceedings, 21(1 Pt 3), 2926-8, February 1989 Abstract
  • Sanders JE, Buckner CD, Sullivan K, Doney K, Appelbaum F, Witherspoon R, Anasetti C, Storb R, Thomas ED, Growth and development after bone marrow transplantation, Progress in Clinical and Biological Research, 309, 375-82, 1989 Abstract
  • Agosti JM, Sprenger JD, Lum LG, Witherspoon RP, Fisher LD, Storb R, Henderson WR Jr, Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation, 319(25), 1623-8, December 1988 Abstract
  • Anasetti C, Storb R, Longton G, Witherspoon R, Doney K, Sullivan KM, Thomas ED, Donor buffy coat cell infusion after marrow transplantation for aplastic anemia, 72(3), 1099-100, September 1988 Abstract
  • Martin PJ, Hansen JA, Torok-Storb B, Durnam D, Przepiorka D, O'Quigley J, Sanders J, Sullivan KM, Witherspoon RP, Deeg HJ, et al., Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants, 3(5), 445-56, September 1988 Abstract
  • Witherspoon RP, Sullivan KM, Lum LG, Goehle S, Atkinson MK, Ochs HD, Doney KC, Hansen JA, Sanders JE, Storb R, Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up, 3(5), 425-35, September 1988 Abstract
  • Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Ovarian function following marrow transplantation for aplastic anemia or leukemia, 6(5), 813-8, May 1988 Abstract
  • Doney K, Buckner CD, Kopecky KJ, Sanders JE, Appelbaum FR, Clift R, Sullivan K, Witherspoon R, Storb R, Thomas ED, Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission, 2(4), 355-63, December 1987 Abstract
  • Witherspoon RP, Navari R, Storb R, Sullivan KM, Doney K, Beatty P, Lum LG, Thomas ED, Treatment of marrow graft recipients with thymopentin, 1(4), 365-71, April 1987 Abstract
  • Doney K, Storb R, Buckner CD, McGuffin R, Witherspoon R, Deeg HJ, Appelbaum FR, Sullivan KM, Thomas ED, Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens, 15(3), 239-42, March 1987 Abstract
  • Sullivan KM, Fefer A, Witherspoon R, Storb R, Buckner CD, Weiden P, Schoch G, Thomas ED, Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation, 244, 391-9, 1987 Abstract
  • Deeg HJ, Sullivan KM, Buckner CD, Storb R, Appelbaum FR, Clift RA, Doney K, Sanders JE, Witherspoon RP, Thomas ED, Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiat, 1(2), 151-7, December 1986 Abstract
  • Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, Deeg HJ, Doney KC, Sullivan KM, Appelbaum FR, et al., Growth and development following marrow transplantation for leukemia, 68(5), 1129-35, November 1986 Abstract
  • Bolger GB, Sullivan KM, Storb R, Witherspoon RP, Weiden PL, Stewart P, Sanders J, Meyers JD, Martin PJ, Doney KC, et al., Second marrow infusion for poor graft function after allogeneic marrow transplantation, 1(1), 21-30, May 1986 Abstract
  • Doney K, Storb R, Buckner CD, Sanders J, Witherspoon R, Thomas ED, Marrow transplantation for treatment of pregnancy-associated aplastic anemia, 13(10), 1080-3, November 1985 Abstract
  • Kennedy MS, Deeg HJ, Storb R, Doney K, Sullivan KM, Witherspoon RP, Appelbaum FR, Stewart P, Sanders J, Buckner CD, et al., Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine, 78(6 Pt 1), 978-83, June 1985 Abstract
  • Thomas ED, Sanders JE, Buckner CD, Papayannopoulou T, Borgna-Pignatti C, De Stefano P, Sullivan KM, Deeg HJ, Witherspoon RP, Appelbaum FR, et al., Marrow transplantation for thalassemia, 445, 417-27, 1985 Abstract
  • Witherspoon RP, Storb R, Shulman H, Buckner CD, Deeg HJ, Clift RA, Sanders JE, Doney K, McDonald G, Sullivan KM, et al., Marrow transplantation in hepatitis-associated aplastic anemia, 17(3), 269-78, October 1984 Abstract
  • Buckner CD, Clift RA, Sanders JE, Stewart P, Bensinger WI, Doney KC, Sullivan KM, Witherspoon RP, Deeg HJ, Appelbaum FR, et al., Marrow harvesting from normal donors, 64(3), 630-4, September 1984 Abstract
  • Witherspoon RP, Deeg HJ, Lum LG, Ochs HD, Hansen JA, Thomas ED, Storb R, Immunologic recovery in human marrow graft recipients given cyclosporine or methotrexate for the prevention of graft-versus-host disease, 37(5), 456-61, May 1984 Abstract
  • Witherspoon RP, Legha SS, Reimer RR, Talley RW, Stuckey WJ, Dixon DO, McCracken JD, Stephens RL, Oishi N, Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study, 68(2), 435-6, February 1984 Abstract
  • Witherspoon RP, Matthews D, Storb R, Atkinson K, Cheever M, Deeg HJ, Doney K, Kalbfleisch J, Noel D, Prentice R, et al., Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease, 37(2), 145-50, February 1984 Abstract
  • Witherspoon RP, Hersman J, Storb R, Ochs H, Goldstein AL, McClure J, Noel D, Weiden PL, Thomas ED, Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting, 55(4), 595-608, December 1983 Abstract
  • Sanders JE, Buckner CD, Leonard JM, Sullivan KM, Witherspoon RP, Deeg HJ, Storb R, Thomas ED, Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation, 36(3), 252-5, September 1983 Abstract
  • Izutsu KT, Sullivan KM, Schubert MM, Truelove EL, Shulman HM, Sale GE, Morton TH, Rice JC, Witherspoon RP, Storb R, Thomas ED, Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease, 35(5), 441-6, May 1983 Abstract
  • Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED, Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with c, 60(3), 714-20, September 1982 Abstract
  • Cheever MA, Fefer A, Greenberg PD, Appelbaum F, Armitage JO, Buckner CD, Sale GE, Storb R, Witherspoon RP, Thomas ED, Treatment of hairy-cell leukemia with chemoradiotherapy and identical-twin bone-marrow transplantation, 307(8), 479-81, August 1982 Abstract
  • Storb R, Tsoi MS, Witherspoon RP, Sullivan K, Lum L, Deeg HJ, Atkinson K, Unique immunologic problems in human bone marrow transplant recipients, 13(3), 1624-7, September 1981 Abstract
  • Witherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, Deeg JH, Sosa R, Noel DR, Atkinson K, Thomas ED, Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antith, 58(2), 360-8, August 1981 Abstract
  • Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED, Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression, 57(2), 267-76, February 1981 Abstract

Profile Details

Last Verified: 1/23/2006

COS Expertise ID #135385
Reference this profile directly: http://myprofile.cos.com/WITHERSPOON5